USFDA Reappoints Vinay Prasad to Top Medical and Scientific Role
New Delhi: Vinay Prasad has regained his role as the U.S. Food and Drug Administration's chief medical and scientific officer, according to an update on the health agency's website.
Last month, Prasad returned to his role overseeing vaccine, gene therapy and blood product regulation at the FDA, a little more than a week after he left. Medical Dialogues team had earlier reported that a spokesperson from the Department of Health and Human Services had stated, “Dr. Prasad did not want to be a distraction to the great work of the FDA … and has decided to return to California and spend more time with his family.”
Also Read: Top USFDA Vaccine Official Vinay Prasad Exits Agency
Prasad, an oncologist who was a fierce critic of U.S. COVID-19 vaccine and mask mandates, was named the director of the Center for Biologics Evaluation and Research by FDA Commissioner Marty Makary in May.
The U.S. Department of Health and Human Services, which oversees the FDA, did not immediately respond to a request From Reuters for comment on Thursday.
In his role as chief medical and scientific officer, Prasad will advise the FDA Commissioner and other senior officials on emerging medical and scientific issues impacting regulatory science and public health.
